Latest Share Chat

Diurnal Nets GBP500,000 From Broker Option Exercise (ALLISS)

Tue, 20th Mar 2018 18:28

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Tuesday said that it has received a letter of notice to exercise the broker option in respect of 263,157 shares, raising GBP500,000 in proceeds for the company.

The company expects to have 61.3 million shares in issue following the previously announced share placing, broker option and conversion of convertible loan.

Shares in Diurnal closed up 0.6% at price 200.20 pence on Tuesday.

Related Shares

More News

28 Oct 2022 21:18

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

21 Oct 2022 21:29

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

14 Oct 2022 15:48

UK shareholder meetings calendar - next 7 days

7 Oct 2022 13:01

Diurnal treatment gets approval from Welsh regulatory body

(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hy...

7 Oct 2022 11:31

Diurnal's 'Efmody' treatment gets thumbs-up for NHS Wales

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Friday that the All-Wales Medicines Strategy Group (AWMSG) has recommen...